SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Feb-20 4:58 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 10-Feb-20 | Grant | 5,213 | -- | -- | 100% 0 to 5.21K | |
08-Mar-18 11:35 AM View: | Bioverativ Inc. (BIVV) | 08-Mar-18 | Disposition | 20,396 | -- | -- | (100%) 20.4K to 0 | |
26-Feb-18 5:09 PM View: | Bioverativ Inc. (BIVV) | 23-Feb-18 | Payment of Exercise | 389 | $104.74 | $40,743.90 | (2%) 20.41K to 20.02K | (< 1%) |
26-Feb-18 5:09 PM View: | Bioverativ Inc. (BIVV) | 22-Feb-18 | Payment of Exercise | 1,235 | $104.30 | $128,810.00 | (6%) 21.64K to 20.41K | (< 1%) |
15-Feb-18 5:02 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Payment of Exercise | 1,141 | $103.52 | $118,116.00 | (5%) 22.78K to 21.64K | (1%) |
15-Feb-18 5:02 PM View: | Bioverativ Inc. (BIVV) | 14-Feb-18 | Option Exercise | 3,744 | -- | -- | 20% 19.04K to 22.78K | |
03-Nov-17 4:11 PM View: | Bioverativ Inc. (BIVV) | 02-Nov-17 | Payment of Exercise | 318 | $53.65 | $17,060.70 | (2%) 19.25K to 18.93K | (96%) |
02-Mar-17 4:09 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Grant | 22,567 | -- | -- | 100% 0 to 22.57K | |
02-Mar-17 4:09 PM View: | Bioverativ Inc. (BIVV) | 28-Feb-17 | Payment of Exercise | 3,518 | $45.83 | $161,214.00 | (16%) 22.57K to 19.05K | (129%) |